1. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 2011; 127:1420–1432.
Article
2. Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol. 1995; 20:462–467.
Article
3. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol. 1998; 7:81–96.
Article
4. Wang IJ, Hsieh WS, Guo YL, Jee SH, Hsieh CJ, Hwang YH, et al. Neuro-mediators as predictors of paediatric atopic dermatitis. Clin Exp Allergy. 2008; 38:1302–1308.
Article
5. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci. 2009; 53:48–54.
Article
6. Wang YH, Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy. 2009; 39:798–806.
Article
7. Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int. 2012; 61:3–17.
Article
8. Ikezawa Z, Komori J, Ikezawa Y, Inoue Y, Kirino M, Katsuyama M, et al. A role of staphyococcus aureus, Interleukin-18, nerve growth factor and semaphorin 3A, an Axon guidance molecule, in pathogenesis and treatment of atopic dermatitis. Allergy Asthma Immunol Res. 2010; 2:235–246.
Article
9. Antúnez C, Torres MJ, López S, Rodriguez-Pena R, Blanca M, Mayorga C, et al. Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol. 2009; 161:547–553.
Article
10. Park TJ, Comer C, Carol A, Lu Y, Hong HS, Rice FL. Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain. J Comp Neurol. 2003; 465:104–120.
Article
11. Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol. 2008; 22:223–228.
Article
12. Jung CH, Cho HH, Choi GJ, Kang SY, Yang NW. The anti-sticking effect of mixture of trisodium phosphate and citric acid on oral streptococcus species. Korean J Microbiol. 2008; 44:289–292.
13. Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, et al. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol. 2008; 128:79–86.
Article
14. Choi DI, Choi JY, Kim YJ, Lee JB, Kim SO, Shin HT, et al. Ethanol extract of peanut sprout exhibits a potent anti-inflammatory activity in both an oxazolone-induced contact dermatitis mouse model and compound 48/80-Treated HaCaT Cells. Ann Dermatol. 2015; 27:142–151.
Article
15. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980; 92:Suppl. S44–S47.
16. Penniston KL, Nakada SY, Holmes RP, Assimos DG. Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products. J Endourol. 2008; 22:567–570.
Article
17. Xiong H, Li Y, Slavik MF, Walker JT. Spraying chicken skin with selected chemicals to reduce attached Salmonella typhimurium. J Food Prot. 1998; 61:272–275.
Article
18. Lee HJ, Yoon NY, Lee NR, Jung M, Kim DH, Choi EH. Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model. Exp Dermatol. 2014; 23:736–741.
Article
19. Grove G, Zerweck C. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis. 2004; 73:135–139.
20. Vilaplana J, Coll J, Trullás C, Azón A, Pelejero C. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm Venereol. 1992; 72:28–33.
21. Darlenski R, Kazandjieva J, Fluhr JW, Maurer M, Tsankov N. Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea. J Dermatol Sci. 2014; 76:151–153.
Article
22. Lodén M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005; 19:672–688.
Article
23. Babilas P, Knie U, Abels C. Cosmetic and dermatologic use of alpha hydroxy acids. J Dtsch Dermatol Ges. 2012; 10:488–491.
Article